BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15173889)

  • 1. CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens.
    Yu XZ; Albert MH; Martin PJ; Anasetti C
    J Clin Invest; 2004 Jun; 113(11):1624-30. PubMed ID: 15173889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.
    Barbon CM; Davies JK; Voskertchian A; Kelner RH; Brennan LL; Nadler LM; Guinan EC
    Am J Transplant; 2014 Feb; 14(2):305-18. PubMed ID: 24410845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.
    Sato M; Storb R; Loretz C; Stone D; Mielcarek M; Sale GE; Rezvani AR; Graves SS
    Transplantation; 2013 Jul; 96(1):34-41. PubMed ID: 23694952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo.
    Tang Q; Smith JA; Szot GL; Zhou P; Alegre ML; Henriksen KJ; Thompson CB; Bluestone JA
    J Immunol; 2003 Feb; 170(3):1510-6. PubMed ID: 12538715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
    Kato K; Cui S; Kuick R; Mineishi S; Hexner E; Ferrara JL; Emerson SG; Zhang Y
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):751-71. PubMed ID: 20116439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent control of acute graft-versus-host disease lethality after immunization with a novel DNA vaccine targeted to B7-1/CD28 costimulatory signaling pathway.
    Luo Y; Liang F; Liu N; Xue H; Song X; Yuan F; Long J; Zhao X; Sun Y; Xi Y
    J Immunother; 2013 Feb; 36(2):82-92. PubMed ID: 23377669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
    Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
    Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA
    J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28-specific antibody prevents graft-versus-host disease in mice.
    Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
    J Immunol; 2000 May; 164(9):4564-8. PubMed ID: 10779758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Vallera DA
    Blood; 1995 May; 85(9):2607-18. PubMed ID: 7537122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of lethal acute GVHD with an agonistic CD28 antibody and rapamycin.
    Albert MH; Yu XZ; Martin PJ; Anasetti C
    Blood; 2005 Feb; 105(3):1355-61. PubMed ID: 15459004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo maturation of allo-specific CD8 CTL and prevention of lupus-like graft-versus-host disease is critically dependent on T cell signaling through the TNF p75 receptor but not the TNF p55 receptor.
    Soloviova K; Puliaiev M; Haas M; Via CS
    J Immunol; 2013 May; 190(9):4562-72. PubMed ID: 23526821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes.
    Keir ME; Latchman YE; Freeman GJ; Sharpe AH
    J Immunol; 2005 Dec; 175(11):7372-9. PubMed ID: 16301644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4(+) and CD8(+) T cells in vivo.
    Habicht A; Kewalaramani R; Vu MD; Demirci G; Blazar BR; Sayegh MH; Li XC
    Am J Transplant; 2007 Dec; 7(12):2683-92. PubMed ID: 17924994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On CD28/CD40 ligand costimulation, common gamma-chain signals, and the alloimmune response.
    Demirci G; Gao W; Zheng XX; Malek TR; Strom TB; Li XC
    J Immunol; 2002 May; 168(9):4382-90. PubMed ID: 11970980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. During acute graft versus host disease CD28 deletion in donor CD8
    Uri A; Lühder F; Kerkau T; Beyersdorf N
    Eur J Immunol; 2018 Dec; 48(12):2055-2067. PubMed ID: 30320878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells.
    Blazar BR; Sharpe AH; Taylor PA; Panoskaltsis-Mortari A; Gray GS; Korngold R; Vallera DA
    J Immunol; 1996 Oct; 157(8):3250-9. PubMed ID: 8871619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells.
    Shi Z; Rifa'i M; Lee YH; Shiku H; Isobe K; Suzuki H
    Immunology; 2008 May; 124(1):121-8. PubMed ID: 18205792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.